Twist Bioscience Corporation , a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Curio Genomics, a pioneer in genomics software, today ...

Precision medicine, also known as personalised medicine, is transforming healthcare by providing tailored treatments to patients suffering from life-threatening conditions. We are all unique, and ...

Exciting news to share with our network! Our team's work has been recently published in the Vaccine Journal. We validated the MSD Multiplex assay to establish serological signatures of SARS-CoV2 ...

Recent efforts in vaccine development have targeted spike proteins from evolving SARS-CoV-2 variants. In this study, we analyzed T cell responses to the XBB.1.5 and BA.2.86 subvariants in individuals ...

NEW! NEW! NEW! Say hello to MSD's NEW instrument - The QuickPlex Q60 MM The Q 60 delivers 5 logs of dynamic range, attomolar sensitivity, multiplexing capability and access to a menu of over 600 ...

Objective To better understand the immune microenvironment of pancreatic ductal adenocarcinomas (PDACs), here we explored the relevance of T and B cell compartmentalisation into tertiary lymphoid ...

The CAPTURE assay isolated exfoliated tumor cells (ETCs) from bile and circulating tumor cells (CTCs) from blood of patients with CCA (CCA+) using magnetic beads coated with two affinity probes: a ...

The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...

MSD has invested $12bn in US capital since 2018. Credit: Katherine Welles/Shutterstock. MSD has opened a $1bn facility in Durham, in the US state of North Carolina, to increase vaccine manufacturing ...